| First Author | Zurek AA | Year | 2014 |
| Journal | J Clin Invest | Volume | 124 |
| Issue | 12 | Pages | 5437-41 |
| PubMed ID | 25365226 | Mgi Jnum | J:219528 |
| Mgi Id | MGI:5621108 | Doi | 10.1172/JCI76669 |
| Citation | Zurek AA, et al. (2014) Sustained increase in alpha5GABAA receptor function impairs memory after anesthesia. J Clin Invest 124(12):5437-41 |
| abstractText | Many patients who undergo general anesthesia and surgery experience cognitive dysfunction, particularly memory deficits that can persist for days to months. The mechanisms underlying this postoperative cognitive dysfunction in the adult brain remain poorly understood. Depression of brain function during anesthesia is attributed primarily to increased activity of gamma-aminobutyric acid type A receptors (GABA(A)Rs), and it is assumed that once the anesthetic drug is eliminated, the activity of GABA(A)Rs rapidly returns to baseline and these receptors no longer impair memory. Here, using a murine model, we found that a single in vivo treatment with the injectable anesthetic etomidate increased a tonic inhibitory current generated by alpha5 subunit-containing GABA(A)Rs (alpha5GABA(A)Rs) and cell-surface expression of alpha5GABA(A)Rs for at least 1 week. The sustained increase in alpha5GABA(A)R activity impaired memory performance and synaptic plasticity in the hippocampus. Inhibition of alpha5GABA(A)Rs completely reversed the memory deficits after anesthesia. Similarly, the inhaled anesthetic isoflurane triggered a persistent increase in tonic current and cell-surface expression of alpha5GABA(A)Rs. Thus, alpha5GABA(A)R function does not return to baseline after the anesthetic is eliminated, suggesting a mechanism to account for persistent memory deficits after general anesthesia. |
